-
Posted by
Two Blokes Jun 13 -
Filed in
Stock
-
5 views
American Vanguard Corporation is strategically positioned in the growing biopesticides market, benefiting from regulatory and consumer shifts away from conventional crop chemicals. Despite operational streamlining and improved working capital, Q1 2025 results revealed sharp revenue and margin declines due to aggressive pricing and regional setbacks. Financial and governance issues, including delayed reporting and slashed dividends, have forced AVD into a defensive liquidity stance, curbing innovation and growth.
